Citigroup’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.8K | Sell |
|
|||||
|
2025
Q1 | $40.8K | Buy |
|
|||||
|
2024
Q4 | $36.6K | Buy |
|
|||||
|
2024
Q3 | $109K | Buy |
|
|||||
|
2024
Q2 | $46.1K | Sell |
|
|||||
|
2024
Q1 | $488K | Buy |
|
|||||
|
2023
Q4 | $57 | Sell |
|
|||||
|
2023
Q3 | $1.34K | Sell |
|
|||||
|
2023
Q2 | $2.17K | Sell |
|
|||||
|
2023
Q1 | $1.53M | Buy |
|
|||||
|
2022
Q4 | $1.84M | Sell |
|
|||||
|
2022
Q3 | $3.48M | Buy |
|
|||||
|
2022
Q2 | $2.66M | Buy |
|
|||||
|
2022
Q1 | $1.14M | Sell |
|
|||||
|
2021
Q4 | $3.83M | Buy |
|
|||||
|
2021
Q3 | $2.67M | Sell |
|
|||||
|
2021
Q2 | $5.75M | Buy |
|
|||||
|
2021
Q1 | $4.66M | Buy |
|
|||||
|
2020
Q4 | $1.07M | Buy |
|
|||||
|
2020
Q3 | $957K | Sell |
|
|||||
|
2020
Q2 | $7.39M | Buy |
|
|||||
|
2020
Q1 | $761K | Buy |
|
|||||
|
2019
Q4 | $276K | Buy |
|
|||||
|
2019
Q3 | $127K | Sell |
|
|||||
|
2019
Q2 | $257K | Buy |
|
|||||
|
2019
Q1 | $273K | Sell |
|
|||||
|
2018
Q4 | $1.02M | Buy |
|
|||||
|
2018
Q3 | $1.09M | Buy |
|
|||||
|
2018
Q2 | $609K | Sell |
|
|||||
|
2018
Q1 | $912K | Sell |
|
|||||
|
2017
Q4 | $890K | Buy |
|
|||||
|
2017
Q3 | $994K | Buy |
|
|||||
|
2017
Q2 | $414K | Buy |
|
|||||
|
2017
Q1 | $295K | Sell |
|
|||||
|
2016
Q4 | $1.22M | Buy |
|
|||||
|
2016
Q3 | $717K | Buy |
|
|||||
|
2016
Q2 | $542K | Sell |
|
|||||
|
2016
Q1 | $978K | Buy |
|
|||||
|
2015
Q4 | $405K | Sell |
|
|||||
|
2015
Q3 | $740K | Buy |
|
|||||
|
2015
Q2 | $510K | Sell |
|
|||||
|
2015
Q1 | $536K | Sell |
|
|||||
|
2014
Q4 | $691K | Buy |
|
|||||
|
2014
Q3 | $632K | Buy |
|
|||||
|
2014
Q2 | $568K | Sell |
|
|||||
|
2014
Q1 | $1.06M | Sell |
|
|||||
|
2013
Q4 | $1.01M | Buy |
|
|||||
|
2013
Q3 | $682K | Buy |
|
|||||
|
2013
Q2 | $228K | Buy |
|